CYP2E1 and familial dilated cardiomyopathy: Importantly, future studies using antioxidant therapy in cMyBP-C(t/t) DCM mice or knockdown/downregulation of ROS generators such as CYP2E1 may lead to a reduction in interstitial fibrosis and myocardial remodeling and could improve cardiac function.